Remimazolam provides better hemodynamic stability than propofol in hypertensive surgical patients: a randomized single-blinded trial
For hypertensive patients, remimazolam provides superior hemodynamic stability over propofol, evidenced by fewer hypotensive episodes, reduced norepinephrine requirements, and attenuated perturbations in CO and SVR, without delaying recovery. It represents a valuable anesthetic alternative for this high-risk cohort.
Authors
- Haiyan Yu (ORCID: https://orcid.org/0000-0001-6472-1366)
- Jun Xiong (ORCID: https://orcid.org/0000-0001-9083-4751)
- Dongying Chen (ORCID: https://orcid.org/0000-0003-0167-3285)
- Ping Wang (ORCID: https://orcid.org/0009-0003-5495-7617)
- Yanyan Sun (ORCID: https://orcid.org/0000-0002-6735-5725)
Institutions
- Shenzhen University (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
Publication Details
- Journal
- Journal of Anesthesia
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1007/s00540-025-03644-1
- Citations
- 3
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 6.57